Cashu FinanceCashu Finance
  • Terminal
  • Pulse
  • Spotlight
  • News
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Healthcare
  3. OTC
  4. CSLLY

Market Cap: $127.4B

CL

CSL Limited

CSLLY
OTC (Other OTC)USD
Invest in CSLLY
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksScreenersAboutAuthorsAdvertisersBrokersConferencesContact

Legal

Terms of ServicePrivacy PolicyEditorial PolicyCorrections Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

Executive

Gordon Naylor DipCompSc

MD, Chief Executive Officer & Executive Director

Compensation
$2,253,748
Ken Lim

Chief Financial Officer

Compensation
$779,851
Mary Oates

Executive VP & COO

Compensation
Compensation not disclosed
Gregory Boss

Executive VP of Legal & Group General Counsel

Compensation
$1,095,171
Mark Hill

Chief Digital Information Officer & Executive Vice President

Compensation
Compensation not disclosed
William Mezzanotte

Chief Medical Officer, Executive Vice President and Head of Research & Development

Compensation
$1,455,733
Deirdre BeVard

Senior Vice President of Research & Development Strategic Operations

Compensation
Compensation not disclosed
Amy Van Buren

Chief People Officer

Compensation
Compensation not disclosed
Andy Schmeltz

Chief Commercial Officer

Compensation
$1,588,530
Herve Gisserot

Executive VP of Business Development & Enterprise Alliance Management

Compensation
Compensation not disclosed
Kate Sophie Priestman

Chief Corporate & External Affairs Officer

Compensation
Compensation not disclosed
Mark Dehring

Head of Investor Relations

Compensation
Compensation not disclosed
Michelle Rees

Head of Investor Relations

Compensation
Compensation not disclosed
Stephen Marlow

Executive VP & GM of CSL Plasma

Compensation
Compensation not disclosed